Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
When we looked for a buy option, we found none for single orders
Mirum CEO Chris Peetz said in a statement that Livmarli could have a transformational impact for patients with cholestatic pruritis associated with PFIC. March 11: In a press release Monday, Viatris and Mapi Pharma announced that the FDA has rejected their multiple sclerosis hopeful GA Depot 40, which the companies had proposed as a treatment for relapsing forms of the disease
PMCID: PMC1975347
Individuals with conditions such as pernicious anemia, gastrointestinal disorders, or post-surgical digestive changes may lack sufficient intrinsic factor, making oral absorption inefficient
Loss of ABHD15 impairs the anti-lipolytic action of insulin by altering PDE3B stability and contributes to insulin resistance
US$ 20.85
US$ 22.37
US$ 23.42
